Extract of un-audited standalone and consolidated financial results of the company for the quarter and nine month ended on 31.12.2025 published in Free press journal English edition and ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Medi-Caps Limited has submitted newspaper clippings of its un-audited financial results for Q3 FY26 (ended Dec 31, 2025) and the nine-month period, which were approved by the board on February 11, 2026 and published on February 13, 2026. Standalone total income from operations for Q3 was Rs 77.28 lakhs, a sharp fall from Rs 241.66 lakhs in the year-ago quarter, though it improved from Rs 26.04 lakhs in the preceding quarter. For the nine-month period, revenue rose modestly to Rs 429.94 lakhs from Rs 402.30 lakhs, but net profit after tax fell sharply to Rs 76.58 lakhs from Rs 204.50 lakhs a year earlier. Standalone EPS for the nine months stood at Rs 0.61, down from Rs 1.64 in the same period last year. Consolidated figures mirror the standalone numbers, indicating no major contribution from subsidiaries.
Profitability has weakened significantly on a year-on-year basis even as nine-month revenue ticked up, which could pressure sentiment in the stock. However, the sequential improvement in quarterly income and profit from Q2 to Q3 may offer some near-term relief for shareholders.